Prevalence of Mild Cognitive Impairment in Community-Dwelling Chinese Populations Aged over 55 years: A Meta-Analysis and Systematic Review

Yuan Lü, Chaojie Liu, Dehua Yu, Sally Fawkes, Jia Ma, Min Zhang, Chunbo LiResearch 2020 · DOI

Introduction

As the world’s most populous middle-income country, China faces a significant and escalating burden of dementia, currently accounting for approximately 25% of global cases. Mild Cognitive Impairment (MCI) represents the critical transition phase between normal cognitive aging and overt dementia. Given that there is currently no cure for dementia, identifying and intervening during the MCI phase is considered the most cost-effective strategy for managing the disease and potentially delaying progression.

Prior epidemiological data in China have been inconsistent, with reported MCI prevalence rates ranging from 0.8% to over 20%. These discrepancies are often attributed to variations in study settings, diagnostic criteria, and age brackets. This systematic review and meta-analysis aims to provide a definitive, synthesized estimate of MCI and its amnesic subtype (aMCI) specifically for community-dwelling adults aged 55 and older in China.

Methods

This study followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) protocol. A comprehensive search was conducted across ten electronic databases, including both English (e.g., PubMed, Embase) and Chinese (e.g., CNKI, Sinomed) sources, for studies published up to March 1, 2020.

Key methodological features included:

  • Inclusion Criteria: Original studies focused on community-dwelling populations aged ≥55 with confirmed MCI or aMCI diagnoses.
  • Quality Assessment: Two independent reviewers utilized the Risk of Bias Tool (based on the GRADE scheme) to evaluate the external and internal validity of the included studies.
  • Statistical Analysis: A random-effects model was employed to calculate pooled prevalence, accounting for expected variations between studies. Subgroup analyses and meta-regression were performed to explore the influence of variables such as age, gender, education, and diagnostic tools.

Results

The meta-analysis synthesized data from 41 eligible studies, comprising a total sample size of 112,632 participants.

Pooled Prevalence

The pooled prevalence of MCI among Chinese community-dwelling populations over 55 years old was 12.2% (95% CI: 10.6%–14.2%). The prevalence for the amnesic subtype (aMCI) was 10.9% (95% CI: 7.7%–15.4%). Notably, aMCI accounted for 66.5% of all MCI cases, which is significant as this subtype is the most likely to progress to Alzheimer’s Disease.

Demographic Drivers

  • Age: Prevalence showed a sharp upward trend with age, nearly tripling from 7.6% in the 55–59 age group to 23.6% for those aged 80 and older.
  • Education: Education served as a clear protective factor. Participants with less than a primary school education had a prevalence of 17.2%, whereas high school graduates had a prevalence of only 6.3%.
  • Gender and Living Situation: Women and individuals living alone exhibited higher MCI prevalence rates.
  • Geography: Rural residents showed a higher prevalence (13.6%) compared to urban dwellers (11.4%), a difference potentially linked to "cognitive reserve" stemming from higher income and educational opportunities in urban areas.

Diagnostic Sensitivity

Prevalence rates varied significantly based on the diagnostic criteria used. The DSM-IV criteria yielded the highest prevalence (13.5%), followed by the Petersen criteria (12.9%), and the NIA-AA criteria (10.3%). This highlights how the choice of diagnostic tool can fundamentally alter the understanding of population health.

Discussion and Limitations

The findings suggest that MCI prevalence in China is higher than in some other countries, which may be due to the adoption of more relaxed diagnostic criteria in certain studies. However, the high prevalence among specific subgroups—particularly rural residents and those with low education—provides a roadmap for targeted public health interventions.

Several limitations were identified:

  • Heterogeneity: Significant statistical variation (I² > 75%) existed between studies, likely due to China's vast geographic and socioeconomic diversity.
  • Representation: The data focused primarily on Han Chinese populations, leaving a gap in knowledge regarding China’s 55 ethnic minority groups.
  • Study Design: Most included studies were cross-sectional. Future research should prioritize longitudinal designs to track the progression from MCI to dementia within the Chinese context.

In conclusion, this study establishes a robust baseline for MCI prevalence in China, emphasizing the need for standardized diagnostic protocols and targeted support for vulnerable aging populations.

Summary updated

Abstract

Abstract Background: Mild cognitive impairment (MCI) is an intermediate phase between normal cognitive ageing and overt dementia, with amnesic MCI (aMCI) being the dominant subtype. This study aims to synthesise the prevalence results of MCI and aMCI in community-dwelling populations in China through a meta-analysis and systematic review. Methods: The study followed the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) protocol. English and Chinese studies published before 1 March 2020 were searched from ten electronic bibliographic databases. Two reviewers screened for relevance of the studies against the pre-defined inclusion and exclusion criteria and assessed the quality of the included studies using the Risk of Bias Tool independently. A random-effect model was adopted to estimate the prevalence of MCI and aMCI, followed by subgroup analyses and meta-regression. Sensitivity and publication bias tests were performed to verify the robustness of the meta-analyses. Results: A total of 41 studies with 112,632 participants were included in the meta-analyses. The Chinese community-dwelling populations over 55 years old had a pooled prevalence of 12.2% [95% confidence interval (CI): 10.6%, 14.2%] for MCI and 10.9% [95% CI: 7.7%, 15.4%] for aMCI, respectively. The prevalence of MCI increased with age. The American Psychiatric Association’s Diagnostic tool (DSM-IV) generated the highest MCI prevalence (13.5%), followed by the Petersen criteria (12.9%), and the National Institute on Aging Alzheimer’s Association (NIA-AA) criteria (10.3%). Women, rural residents, and those who lived alone and had low levels of education had higher MCI prevalence than others. ​ Conclusion: Higher MCI prevalence was identified in community-dwelling populations in China compared with some other countries, possibly due to more relaxed criteria being adopted for confirming the diagnosis. The study shows that aMCI accounts for 66.5% of MCI, which is consistent with findings of studies undertaken elsewhere. Systematic review registration number: PROSPERO CRD42019134686
BibTeX
@inproceedings{lu2020prevalence,
  author = {Yuan Lü and Chaojie Liu and Dehua Yu and Sally Fawkes and Jia Ma and Min Zhang and Chunbo Li},
  title = {{Prevalence of Mild Cognitive Impairment in Community-Dwelling Chinese Populations Aged over 55 years: A Meta-Analysis and Systematic Review}},
  booktitle = {Research},
  year = {2020},
  doi = {10.21203/rs.3.rs-38966/v1},
}
Figure